• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过机器学习算法鉴定肺腺癌淋巴结转移的特征基因及其作用。

Identification of the Characteristic Genes and their Roles in Lung Adenocarcinoma Lymph Node Metastasis through Machine Learning Algorithm.

机构信息

Department of Cardiothoracic Surgery, Jingzhou Central Hospital, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, Hubei, China.

出版信息

Comput Math Methods Med. 2022 Oct 12;2022:1968829. doi: 10.1155/2022/1968829. eCollection 2022.

DOI:10.1155/2022/1968829
PMID:36277017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9581663/
Abstract

BACKGROUND

Lymph node metastasis is an important route of lung cancer metastasis and can significantly affect the survival of lung cancer.

METHODS

All the analysis was conducted out in the R software. Expression profile and clinical information of lung adenocarcinoma (LUAD) patients were downloaded from The Cancer Genome Atlas database.

RESULTS

In our study, we firstly identified the characteristic genes of lymph node metastasis in LUAD through two machine learning algorithms, least absolute shrinkage and selection operator (LASSO) logistic regression, and SVM-RFE algorithms. Ten characteristic genes were finally identified, including , , , , , , , , , and . Next, we performed univariate Cox regression, LASSO regression, and multivariate Cox regression sequentially to construct a prognosis model based on , , and , which had a good prognosis prediction efficiency in both training and validation cohorts. Univariate and multivariate analysis indicated that our model is a risk factor independent of other clinical features. Pathway enrichment analysis showed that in the high-risk patients, the pathway of MYC target, unfolded protein response, interferon alpha response, DNA repair, reactive oxygen species pathway, and glycolysis were significantly enriched. Among three model genes, aroused our interest and therefore was selected for further analysis. KM survival curves showed that the patients with higher might have better disease-free survival and progression-free survival. Further, pathway enrichment, genomic instability, immune infiltration, and drug sensitivity analysis were performed to in-deep explore the role of in LUAD.

CONCLUSIONS

Results showed that the signature based on , , and is a useful tool to predict prognosis and lung cancer lymph node metastasis.

摘要

背景

淋巴结转移是肺癌转移的重要途径,可显著影响肺癌患者的生存。

方法

所有分析均在 R 软件中进行。从癌症基因组图谱数据库中下载肺腺癌 (LUAD) 患者的表达谱和临床信息。

结果

在我们的研究中,我们首先通过两种机器学习算法,最小绝对值收缩和选择算子 (LASSO) 逻辑回归和 SVM-RFE 算法,确定 LUAD 淋巴结转移的特征基因。最终确定了 10 个特征基因,包括、、、、、、、、和。接下来,我们依次进行单因素 Cox 回归、LASSO 回归和多因素 Cox 回归,构建基于、、和的预后模型,该模型在训练和验证队列中均具有良好的预后预测效率。单因素和多因素分析表明,我们的模型是独立于其他临床特征的危险因素。通路富集分析表明,在高危患者中,MYC 靶标、未折叠蛋白反应、干扰素 α 反应、DNA 修复、活性氧途径和糖酵解途径显著富集。在三个模型基因中,引起了我们的兴趣,因此选择其进行进一步分析。KM 生存曲线表明,较高的患者可能具有更好的无病生存和无进展生存。进一步进行通路富集、基因组不稳定性、免疫浸润和药物敏感性分析,以深入探讨在 LUAD 中的作用。

结论

结果表明,基于、、和的特征签名是预测预后和肺癌淋巴结转移的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/3bc3f1cca8b3/CMMM2022-1968829.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/2e3821071232/CMMM2022-1968829.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/c0feb6a46181/CMMM2022-1968829.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/f019fd8c45d3/CMMM2022-1968829.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/179951dd5394/CMMM2022-1968829.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/7a51fbfbf245/CMMM2022-1968829.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/93ff0f20fbd9/CMMM2022-1968829.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/b9962fe6d945/CMMM2022-1968829.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/3bc3f1cca8b3/CMMM2022-1968829.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/2e3821071232/CMMM2022-1968829.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/c0feb6a46181/CMMM2022-1968829.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/f019fd8c45d3/CMMM2022-1968829.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/179951dd5394/CMMM2022-1968829.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/7a51fbfbf245/CMMM2022-1968829.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/93ff0f20fbd9/CMMM2022-1968829.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/b9962fe6d945/CMMM2022-1968829.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/9581663/3bc3f1cca8b3/CMMM2022-1968829.008.jpg

相似文献

1
Identification of the Characteristic Genes and their Roles in Lung Adenocarcinoma Lymph Node Metastasis through Machine Learning Algorithm.通过机器学习算法鉴定肺腺癌淋巴结转移的特征基因及其作用。
Comput Math Methods Med. 2022 Oct 12;2022:1968829. doi: 10.1155/2022/1968829. eCollection 2022.
2
A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.一项通过机器学习策略确定肺腺癌新预后预测模型的大型队列研究。
BMC Cancer. 2019 Sep 5;19(1):886. doi: 10.1186/s12885-019-6101-7.
3
[Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].[肺腺癌自噬相关基因预后风险评分模型的构建与验证]
Zhongguo Fei Ai Za Zhi. 2021 Aug 20;24(8):557-566. doi: 10.3779/j.issn.1009-3419.2021.103.09. Epub 2021 Jul 14.
4
Construction of Lymph Node Metastasis-Related Prognostic Model and Analysis of Immune Infiltration Mode in Lung Adenocarcinoma.构建肺腺癌淋巴结转移相关预后模型并分析免疫浸润模式。
Comput Math Methods Med. 2022 Jun 29;2022:3887857. doi: 10.1155/2022/3887857. eCollection 2022.
5
Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.泛癌症分析免疫细胞浸润鉴定出肺腺癌预后免疫细胞特征评分(ICCS)。
Front Immunol. 2020 Jun 30;11:1218. doi: 10.3389/fimmu.2020.01218. eCollection 2020.
6
A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.一种新的与铁死亡相关的基因模型用于肺腺癌的预后预测。
BMC Pulm Med. 2021 Jul 13;21(1):229. doi: 10.1186/s12890-021-01588-2.
7
A Recurrence-Specific Gene-Based Prognosis Prediction Model for Lung Adenocarcinoma through Machine Learning Algorithm.基于机器学习算法的肺腺癌复发特异性基因预后预测模型。
Biomed Res Int. 2020 Nov 7;2020:9124792. doi: 10.1155/2020/9124792. eCollection 2020.
8
Comprehensive Analysis and Reinforcement Learning of Hypoxic Genes Based on Four Machine Learning Algorithms for Estimating the Immune Landscape, Clinical Outcomes, and Therapeutic Implications in Patients With Lung Adenocarcinoma.基于四种机器学习算法的低氧基因综合分析与强化学习,用于评估肺腺癌患者的免疫景观、临床结局和治疗意义。
Front Immunol. 2022 Jun 10;13:906889. doi: 10.3389/fimmu.2022.906889. eCollection 2022.
9
Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.预测涉及人肺腺癌进展的失调竞争内源性 RNA 特征。
Cancer Biomark. 2020;29(3):399-416. doi: 10.3233/CBM-200133.
10
Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.综合分析包含脂质代谢和免疫相关基因的新型标志物,用于评估肺腺癌的预后和免疫图谱。
Front Immunol. 2022 Aug 25;13:950001. doi: 10.3389/fimmu.2022.950001. eCollection 2022.

引用本文的文献

1
A Holistic Approach to Implementing Artificial Intelligence in Lung Cancer.肺癌中实施人工智能的整体方法。
Indian J Surg Oncol. 2025 Feb;16(1):257-278. doi: 10.1007/s13193-024-02079-6. Epub 2024 Sep 5.

本文引用的文献

1
Integrated analysis of the M2 macrophage-related signature associated with prognosis in ovarian cancer.与卵巢癌预后相关的M2巨噬细胞相关特征的综合分析。
Front Oncol. 2022 Aug 26;12:986885. doi: 10.3389/fonc.2022.986885. eCollection 2022.
2
CCL19 associates with lymph node metastasis and inferior prognosis in patients with small cell lung cancer.CCL19与小细胞肺癌患者的淋巴结转移及预后不良相关。
Lung Cancer. 2021 Dec;162:194-202. doi: 10.1016/j.lungcan.2021.11.003. Epub 2021 Nov 11.
3
The impact of pathological lymph node metastasis with lymphatic invasion on the survival of patients with clinically node-negative non-small cell lung cancer: A multicenter study.
病理性淋巴结转移伴淋巴血管侵犯对临床淋巴结阴性非小细胞肺癌患者生存的影响:一项多中心研究。
Lung Cancer. 2021 Aug;158:9-14. doi: 10.1016/j.lungcan.2021.05.029. Epub 2021 May 29.
4
COL5A2 Promotes Proliferation and Invasion in Prostate Cancer and Is One of Seven Gleason-Related Genes That Predict Recurrence-Free Survival.COL5A2促进前列腺癌的增殖和侵袭,是预测无复发生存的七个与Gleason评分相关的基因之一。
Front Oncol. 2021 Mar 18;11:583083. doi: 10.3389/fonc.2021.583083. eCollection 2021.
5
Targeting UHRF1-dependent DNA repair selectively sensitizes KRAS mutant lung cancer to chemotherapy.靶向 UHRF1 依赖性 DNA 修复可选择性地增强 KRAS 突变型肺癌对化疗的敏感性。
Cancer Lett. 2020 Nov 28;493:80-90. doi: 10.1016/j.canlet.2020.08.008. Epub 2020 Aug 16.
6
Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC).环状 RNA circ-CPA4/let-7 miRNA/PD-L1 轴调控非小细胞肺癌(NSCLC)中的细胞生长、干性、耐药性和免疫逃逸。
J Exp Clin Cancer Res. 2020 Aug 3;39(1):149. doi: 10.1186/s13046-020-01648-1.
7
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project.建立协调肿瘤突变负荷(TMB)的指南:不同诊断平台之间 TMB 定量分析变异的计算评估:癌症研究之友 TMB 协调项目第一阶段。
J Immunother Cancer. 2020 Mar;8(1). doi: 10.1136/jitc-2019-000147.
8
Large-scale public data reuse to model immunotherapy response and resistance.大规模公共数据再利用以模拟免疫疗法反应和耐药性。
Genome Med. 2020 Feb 26;12(1):21. doi: 10.1186/s13073-020-0721-z.
9
CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1.环状 RNA-ENO1 通过上调其宿主基因 ENO1 促进肺腺癌中的糖酵解和肿瘤进展。
Cell Death Dis. 2019 Nov 25;10(12):885. doi: 10.1038/s41419-019-2127-7.
10
LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis.LINC01123,一种 c-Myc 激活的长非编码 RNA,通过 miR-199a-5p/c-Myc 轴促进非小细胞肺癌的增殖和有氧糖酵解。
J Hematol Oncol. 2019 Sep 5;12(1):91. doi: 10.1186/s13045-019-0773-y.